News From The American Chemical Society, June 24, 2009
Potential new drugs: 970 million and still counting Like astronomers counting stars in the familiar universe of outer space, chemists in Switzerland are reporting the latest results of a survey of chemical space - the so-called chemical universe where tomorrow’s miracle drugs may reside. The scientists conclude, based on this phase of the ongoing count, that there are 970 million chemicals suitable for study as new drugs.
Scientists Receive 4.3 Million For Pioneering Asthma And Allergy-Prevention Research, London
Researchers at St George’s, University of London have been awarded 4.3 million by the Wellcome Trust for the development of a unique new class of drugs to target the root cause of asthma and allergies. The new Allergen Delivery Inhibitors may be superior to existing medicines, which mainly relieve symptoms. The research team, led by Professor Clive Robinson, has identified novel, drug-like chemical compounds that combat asthma and allergic diseases of the nose, eyes and skin.
Top Food Scientist To Target Hidden Fish Allergens, Pork, With New Tests
The odds of contracting mad cow disease from banned or adulterated bovine protein lurking in raw or processed food for humans or meat-bone meal for livestock have declined over the past decade. So have the risks of purchasing fishy imposters billed as red snapper, ground beef that isn’t all cow, or spoiled meat that doesn’t look or smell bad yet.
Virtual Patient To Improve Treatment For Allergy Sufferers
Keele University has developed a new programme to be used with its innovative Virtual Patient system to help pharmacists train in dispensing medication and providing advice on the treatment of hay fever and allergies. With the summer fast approaching and pollen counts set to rise, the number of people seeking help for allergies will be on the increase.
American Lung Association Teams With The AAAAI To Award Research Grants To Study Allergic Respiratory Disease
The American Lung Association and the American Academy of Allergy, Asthma & Immunology are partnering to further clinical research to benefit the estimated 40 to 50 million of Americans living with allergic diseases such as asthma. Through the Allergic Respiratory Diseases Award, the American Lung Association and the American Academy of Allergy, Asthma & Immunology will award up to three, two-year research grants valued at $50,000 annually to outstanding investigators.
Early Infection And Protection Against Allergies?
When infected, the body has two types of immune defence to deploy innate immunity and acquired immunity. In her dissertation, Shanie Saghafian Hedengren studies monocytes, a type of white blood corpuscles that are part of the innate immune system. “Innate immunity plays a crucial role at the beginning of life as protection against bacteria and other microbes, since the acquired immune system is not fully developed at that stage.
Knocking The Wind Out Of Asthmatics: Help From Hippocrates
Last week the FDA knocked the wind out of asthmatics by requesting the manufacturers of Singulair, a popular leukotriene blocking asthma and allergy drug, to upgrade their warning against psychotic side effects. Further respiratory distress was imposed on Zicam users when the FDA also last week announced warnings that the drug may cause a loss of smell.
Urologist And Allergist Explore Link Between Allergies And Interstitial Cystitis
Allergy testing and treatment may offer a new therapeutic option for many patients with interstitial cystitis (IC). IC is a severely painful bladder condition affecting as many as 8 million women and 1.5 million men in the United States. Patients and the providers who treat them have long noticed a correlation between allergies and IC.
New All-Natural Capsaicin-Based, Zinc-Free Nasal Spray Is Effective In Relieving Symptoms Of Allergic Rhinitis
Researchers from Strategic BioSciences, together with investigators from the Institute for Asthma and Allergy (Wheaton, MD) reported that the new all-natural product is safe and effective in relieving symptoms of allergic rhinitis. MucoAd is a mucoadhesive molecule (hypromellose) that prolongs contact with the nasal surface so that the nasal spray is well tolerated, lasts longer, and repeat dosing is needed less frequently.
Moisture And Humidity Tips From DampRid May Aid Allergy Suffers
With one in five, or 60 million, Americans suffering from some kind of allergy, spring and summer can be a difficult time of year as pollen, moisture and humidity increase. According to the Asthma and Allergy Foundation of America, allergies are considered the fifth leading chronic disease and are a major cause of work absenteeism, resulting in nearly four million missed or lost workdays each year.